Lea Scheppke
- Cancer Research top 5%
- Ophthalmology top 2%
- Retinal Diseases and Treatments 7
- Glaucoma and retinal disorders 3
- Molecular Biology top 10%
- Retinal Development and Disorders 3
- Angiogenesis and VEGF in Cancer 3
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 2
- Neurology top 10%
-
- Retinal Imaging and Analysis 2
-
- Moyamoya disease diagnosis and treatment 1
-
- Genetic Associations and Epidemiology 1
- Co-authors
- David A. ChereshEric A. MurphyDavid J. ShieldsLisette M. AcevedoMartin FriedlanderSara M. WeisJianhua HuangJoshua I. Greenberg
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Lea Scheppke
13 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 474
- Ophthalmology 283
- Molecular Biology 976
- Immunology and Allergy 71
- Neurology 73
Countries citing papers authored by Lea Scheppke
This map shows the geographic impact of Lea Scheppke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Scheppke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Scheppke more than expected).
Fields of papers citing papers by Lea Scheppke
This network shows the impact of papers produced by Lea Scheppke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Scheppke. The network helps show where Lea Scheppke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lea Scheppke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 22 | |
| 5 | 2021 | 32 | |
| 6 | 2017 | 85 | |
| 7 | 2015 | 41 | |
| 8 | 2011 | 116 | |
| 9 | 2010 | 418 | |
| 10 | A role for VEGF as a negative regulator of pericyte function and vessel maturationbreakdown → | 2008 | 501 |
| 11 | 2008 | 99 | |
| 12 | 2007 | 127 | |
| 13 | 2005 | 29 |
About Lea Scheppke
Lea Scheppke is a scholar working on Ophthalmology, Immunology and Allergy, Biophysics, Nephrology and Rheumatology, having authored 13 papers that have together received 1.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (7 papers), Retinal Development and Disorders (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Glaucoma and retinal disorders (3 papers), Retinal Imaging and Analysis (2 papers), Cell Adhesion Molecules Research (2 papers), Moyamoya disease diagnosis and treatment (1 paper) and Genetic Associations and Epidemiology (1 paper). The work is most often cited by research in Cancer Research (474 citations), Ophthalmology (283 citations), Molecular Biology (976 citations), Immunology and Allergy (71 citations) and Neurology (73 citations). Lea Scheppke has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David A. Cheresh, Eric A. Murphy, David J. Shields, Lisette M. Acevedo, Martin Friedlander, Sara M. Weis, Jianhua Huang, Joshua I. Greenberg, Christian Stockmann and Niren Angle. Their work appears in journals such as Communications Biology, Blood, Nature Medicine, Nature Genetics and Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.